Ascentage Pharma Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 583

Employees

  • Stock Symbol
  • 06855

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.13
  • (As of Thursday Closing)

Ascentage Pharma General Information

Description

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Stock Exchange
HKG
Corporate Office
  • Number 68 Xinghu Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0512 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascentage Pharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.13 $2.15 $2.11 - $3.60 $623M 290M 1.44M -$0.46

Ascentage Pharma Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,027,314 1,027,314 848,823 816,829
Revenue 31,376 31,376 31,140 4,322
EBITDA (109,687) (109,687) (115,999) (123,012)
Net Income (130,834) (130,834) (131,104) (121,173)
Total Assets 352,734 352,734 410,224 461,251
Total Debt 253,307 253,307 259,842 170,109
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ascentage Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ascentage Pharma‘s full profile, request access.

Request a free trial

Ascentage Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of n
Drug Discovery
Suzhou, China
583 As of 2023
00000
000000000 00000

00000-

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
0000 000000000
Abingdon, United Kingdom
00 As of 0000
00.00
000000 0

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim venia
0000 000000000
Loos, France
00 As of 0000
000.00
000.00 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ascentage Pharma Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neuro-Bio Venture Capital-Backed Abingdon, United Kingdom 00 00.00 000000 0
Alzprotect Venture Capital-Backed Loos, France 00 000.00 0000000000 0 000.00
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 000.00 000000000 000.00
Gilead Sciences Formerly VC-backed Foster City, CA 00000 000.00 0000
To view Ascentage Pharma’s complete competitors history, request access »

Ascentage Pharma Executive Team (8)

Name Title Board Seat Contact Info
Dajun Yang Ph.D Chief Executive Officer & Chairman
Yiqing Chen Chief Financial Officer
Jeff Kmetz Chief Business Officer
Gang Zhu Chief Business Operations Officer
Yifan Zhai Ph.D Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Ascentage Pharma Board Members (9)

Name Representing Role Since
Dajun Yang Ph.D Ascentage Pharma Chief Executive Officer & Chairman 000 0000
David Sidransky MD Self Board Member 000 0000
Dazhong Lv Ascentage Pharma Board Member 000 0000
Lawrence Tian Ph.D YuanMing Capital Board Member 000 0000
Qun Zhao Ascentage Pharma Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Ascentage Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascentage Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ascentage Pharma‘s full profile, request access.

Request a free trial

Ascentage Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Ascentage Pharma and Unity Biotechnology) 01-Feb-2016 00000 0000 Media and Information Services (B2B)
To view Ascentage Pharma’s complete investments history, request access »

Ascentage Pharma ESG

Risk Overview

Risk Rating

Updated September, 27, 2023

26.1 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,173

Rank

00.0

Percentile

Pharmaceuticals

Industry

00 of 909

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 401

Rank

00.00

Percentile

To view Ascentage Pharma’s complete esg history, request access »

Ascentage Pharma FAQs

  • When was Ascentage Pharma founded?

    Ascentage Pharma was founded in 2009.

  • Who is the founder of Ascentage Pharma?

    Dajun Yang Ph.D and Ming Guo Ph.D are the founders of Ascentage Pharma.

  • Who is the CEO of Ascentage Pharma?

    Dajun Yang Ph.D is the CEO of Ascentage Pharma.

  • Where is Ascentage Pharma headquartered?

    Ascentage Pharma is headquartered in Suzhou, China.

  • What is the size of Ascentage Pharma?

    Ascentage Pharma has 583 total employees.

  • What industry is Ascentage Pharma in?

    Ascentage Pharma’s primary industry is Drug Discovery.

  • Is Ascentage Pharma a private or public company?

    Ascentage Pharma is a Public company.

  • What is Ascentage Pharma’s stock symbol?

    The ticker symbol for Ascentage Pharma is 06855.

  • What is the current stock price of Ascentage Pharma?

    As of 18-Apr-2024 the stock price of Ascentage Pharma is $2.13.

  • What is the current market cap of Ascentage Pharma?

    The current market capitalization of Ascentage Pharma is $623M.

  • What is Ascentage Pharma’s current revenue?

    The trailing twelve month revenue for Ascentage Pharma is $31.4M.

  • Who are Ascentage Pharma’s competitors?

    Neuro-Bio, Alzprotect, Amgen, and Gilead Sciences are competitors of Ascentage Pharma.

  • What is Ascentage Pharma’s annual earnings per share (EPS)?

    Ascentage Pharma’s EPS for 12 months was -$0.46.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »